Stephen Brincat

1.2k total citations
9 papers, 478 citations indexed

About

Stephen Brincat is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Stephen Brincat has authored 9 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Stephen Brincat's work include HER2/EGFR in Cancer Research (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Gastric Cancer Management and Outcomes (2 papers). Stephen Brincat is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Gastric Cancer Management and Outcomes (2 papers). Stephen Brincat collaborates with scholars based in United States, Canada and Austria. Stephen Brincat's co-authors include Igor Bondarenko, P. Fumoleau, M Brincat, V. Parsons, K. J. Lafferty, J. W. W. Studd, P B Rylance, Anna Berkenblit, Antonio C. Wolff and Yan Sun and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Stephen Brincat

9 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Brincat United States 7 238 233 195 85 68 9 478
Tommi J. Ahonen Finland 9 283 1.2× 163 0.7× 271 1.4× 167 2.0× 120 1.8× 11 589
Dov Flex Israel 15 369 1.6× 316 1.4× 104 0.5× 133 1.6× 91 1.3× 28 663
Anna Berg Norway 16 167 0.7× 103 0.4× 287 1.5× 88 1.0× 150 2.2× 21 683
David Saavedra-Pérez Spain 9 276 1.2× 163 0.7× 94 0.5× 61 0.7× 142 2.1× 29 580
Jennifer Foglietta Italy 10 283 1.2× 162 0.7× 108 0.6× 41 0.5× 65 1.0× 20 413
Virginia Fisher United States 13 172 0.7× 182 0.8× 123 0.6× 32 0.4× 122 1.8× 26 571
Reinaldo Chacón Argentina 13 302 1.3× 92 0.4× 166 0.9× 79 0.9× 151 2.2× 26 580
Donald I. Twito United States 11 362 1.5× 233 1.0× 122 0.6× 175 2.1× 170 2.5× 13 603
Ellen Wollmer Germany 7 115 0.5× 79 0.3× 181 0.9× 54 0.6× 44 0.6× 12 455
Shen-Yi Li China 4 143 0.6× 63 0.3× 231 1.2× 151 1.8× 112 1.6× 8 788

Countries citing papers authored by Stephen Brincat

Since Specialization
Citations

This map shows the geographic impact of Stephen Brincat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Brincat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Brincat more than expected).

Fields of papers citing papers by Stephen Brincat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Brincat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Brincat. The network helps show where Stephen Brincat may publish in the future.

Co-authorship network of co-authors of Stephen Brincat

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Brincat. A scholar is included among the top collaborators of Stephen Brincat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Brincat. Stephen Brincat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ghosh, Sunita, Elena Fidarova, J.P. Agarwal, et al.. (2017). The International Atomic Energy Agency Randomized Trial on Chemotherapy With or Without Radiation Therapy in Advanced Non–small Cell Lung Cancer (NCT00864331). International Journal of Radiation Oncology*Biology*Physics. 99(2). S103–S104. 2 indexed citations
2.
Fuchs, Charles S., Josep Tabernero, Jiří Tomášek, et al.. (2016). Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab. British Journal of Cancer. 115(8). 974–982. 57 indexed citations
4.
Fuchs, Charles S., Josep Tabernero, Jiří Tomášek, et al.. (2015). Candidate biomarker analyses in gastric or gastro-esophageal junction carcinoma: REGARD trial of single-agent ramucirumab (RAM) vs. placebo (PL).. Journal of Clinical Oncology. 33(15_suppl). 4029–4029. 6 indexed citations
5.
Wolff, Antonio C., Ann Lazar, Igor Bondarenko, et al.. (2012). Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology. 31(2). 195–202. 222 indexed citations
6.
Campone, Mario, Igor Bondarenko, Stephen Brincat, et al.. (2011). Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy. Annals of Oncology. 23(3). 610–617. 77 indexed citations
7.
Pirker, Robert, Stephen Brincat, Peter Kasan, et al.. (2010). Therapy of small cell lung cancer with emphasis on oral topotecan. Lung Cancer. 70(1). 7–13. 12 indexed citations
8.
Brincat, Stephen, et al.. (2009). Recurrence of rectal cancer: a study on patients with rectal cancer referred to Sir Paul Boffa Hospital during 2001-2003. OAR@UM (University of Malta). 21(3). 32–35. 1 indexed citations
9.
Rylance, P B, M Brincat, K. J. Lafferty, et al.. (1985). Natural progesterone and antihypertensive action.. BMJ. 290(6461). 13–14. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026